Moderna’s coronavirus vaccine deal with the U.S., announced last week with a $ 1.525 billion price tag, would be worth far more if all options are exercised—and if the mRNA biotech meets an aggressive timeline for the shot’s arrival. The company stands to gain up to a whopping $ 8.125 billion, according to a Moderna… Read More »
A police officer patrols a deserted Red Square during the pandemic of the novel coronavirus (COVID-19). Valery Sharifulin Russia has rejected international criticism and skepticism toward its coronavirus vaccine, saying that it’s safe and that it works. Russia announced Tuesday that its vaccine had been approved by its health regulators, making it the first coronavirus… Read More »
Article content continued Last month, the company’s co-founder said it was in talks with Russia, Brazil, Chile and Saudi Arabia to conduct Phase 3 trials, which determine whether the vaccine actually protects people against COVID-19 infection. Back in Canada, “we are continuing to wait for the vaccine,” said Scott Halperin, the Dalhousie scientist heading Canada’s… Read More »
The biggest test yet of an experimental COVID-19 vaccine got underway Monday with the first of some 30,000 Americans rolling up their sleeves to receive shots created by the U.S. government as part of the all-out global race to stop the outbreak. The glimmer of hope came even as Google, in one of the gloomiest… Read More »